Loading...
Uploaded by CorporateProfile on Feb 8, 2010
Annamaria from CorporateProfile.com talks about Cleveland Biolabs (CBLI), the recent New York Times article on the negative side effects of chemotherapy, and CBLB502, a new drug that mitigates the adverse effects of radiation
Entertainment
Standard YouTube License
Load more suggestions
Link to this comment:
All Comments (0)